InterGenetics Home


David Ralph, PhD, MBA
Chief Scientific Officer

Dr. Ralph serves as Chief Scientific Officer and brings broad experience in genetic research and the design, development and marketing of genetic-based diagnostics for prostate and bladder cancer.  Dr. Ralph is a co-founder of InterGenetics and co-inventor of its intellectual property.  Dr. Ralph has served in various research and business development capacities with UroCor, a diagnostic services company ultimately acquired by Lab Corp.  He has worked extensively with compliance for FDA regulations and was awarded two patents for his work at UroCor.  He has an in-depth knowledge of state and federal regulatory requirements, genotyping, marketing products to healthcare providers, pharmacogenomics and running large-scale clinical trials.  Prior to his involvement with UroCor, Dr. Ralph worked at the California Institute for Biological Research, a subsidiary of Stratagene, Inc.

Dr. Ralph received a Ph.D. in molecular genetics from Ohio State University before completing a postdoctoral fellowship at Columbia University.  Dr. Ralph completed a second postdoctoral fellowship at the University of Massachusetts Medical School before receiving his M.B.A. from the University of Oklahoma, Price College of Business.

Management Team Menu
- Craig D. Shimasaki, PhD, MBA
  President and CEO

- David A. Ralph, PhD, MBA
  Chief Scientific Officer

- Eldon R. Jupe, PhD
  Vice President for Research
- Sherry Bellack
  Director, Market Relations
- John G. Langdon, MD
  Medical Director
- Fred E. Hiller
  Acting Chief Financial Officer

- Harold E. Box III (Trey), Esq.
  Director, Corporate Resources / Staff Attorney
- Kelly Gentry, RN, MS, MBA
  Director, Medical Relations
- Joseph M. Quashnock, PhD, HCLD(ABB), FACB
  Laboratory Director, Clinical Testing

Career Opportunities Publication and Abstracts Contact InterGenetics